Skip to main content
. 2004 Mar;70(3):1874–1881. doi: 10.1128/AEM.70.3.1874-1881.2004

TABLE 2.

Oligonucleotides used in this study

Oligo- nucleotide Sequence (5′-3′)a Source or reference
Cloning primers
CA-1     GTSGATTCACCSGATGAG This study
CA-2     CCSGATGARCGSCTACAG This study
CA-3     TGSGCSACSGTSACGAAC This study
CA-4     SACGAAYTCSCCCTGSGAC This study
CA-5     GGTCGGGATCAATCTCAACTACATG This study
CA-6     CCTGCTCATCTTCTGCAAACAACTG This study
carF     CGCGGATCCGCAGTGGATTCACCG GATGAG This study
carR     CGGGGTACCCCTGATATCCGTCAG AGCAGCTG This study
Sequencing primers
T7     TAATACGACTCACTATAGGG
SP6     CATACGATTTAGGTGACACTATAG Sigma-Genosys
M13 reverse     CAGGAAACAGCTATGAC Sigma-Genosys
Scar-1     CTCGACCTGGCCGATATCCAC This study
Scar-2     GAGGACGGCTTCTACAAGAC This study
Scar-3     GACGCGCACTTCACCGACCTG This study
Scar-4     GTCGACCTGATCGTCCATCC This study
Sacr-5     GACCTACGACGTGCTCAATC This study
Scar-6     CGTACGACGATGGCATCTC This study
Scar-7     GTGGATATCGGCCAGGTCGAG This study
He-32     GGTGGCAGGATGGAATCGG This study
He-33     CGTCGATTCGCGATTCCCTG This study
a

Restriction cleavage sites are underlined. R represents A or G, Y represents C or T, and S represents G or C.